Clinical Trials Directory

Trials / Completed

CompletedNCT02527187

Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa

Extract Allergen From Betula Verrucosa. Test Sensitivity and Specificity of Diagnostic in Prick Test Preparation.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
201 (actual)
Sponsor
Inmunotek S.L. · Industry
Sex
All
Age
5 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The main objective is to evaluate the concentration of allergen extract of Betula verrucosa that elicit a papule equivalent to that produced by a solution of histamine dihydrochloride 10 mg / ml in size.

Detailed description

Open, prospective, unblinded and non-randomized biological assay. Each patient was tested with four concentrations of allergen and with a histamine and saline solution as positive and negative controls, respectively.

Conditions

Interventions

TypeNameDescription
BIOLOGICAL10 HEP/mL Betula verrucosa allergen extractThe investigational product contained 10 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.
BIOLOGICAL25 HEP/mL Betula verrucosa allergen extractThe investigational product contained 25 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.
BIOLOGICAL50 HEP/mL Betula verrucosa allergen extractThe investigational product contained 50 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.
BIOLOGICAL100 HEP/mL Betula verrucosa allergen extractThe investigational product contained 100 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.

Timeline

Start date
2015-09-01
Primary completion
2016-04-01
Completion
2016-11-01
First posted
2015-08-18
Last updated
2022-05-05
Results posted
2022-05-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02527187. Inclusion in this directory is not an endorsement.